Sleep Disorders Trial, Recruiting NCT06514482 Sponsor: Hospital San Pedro de Logroño Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06514482
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People attending a sleep clinic appointment to receive results from a sleep study for suspected obstructive sleep apnea (OSA)
  • People aged 18 years or older
  • People who have signed the informed consent form

Who may not be able to join:

  • People who are unable to complete questionnaires due to physical or mental difficulties
  • People who have already been diagnosed with another sleep disorder, such as narcolepsy, insomnia, restless legs syndrome, regularly sleeping less than 6 hours per night, or who regularly take sleeping or sedative medications — though people who only use a short-acting benzodiazepine or melatonin may still be considered (confirm with trial site)
  • People whose sleep study results show that more than half of their breathing pauses during sleep are central apneas, or who have a specific abnormal breathing pattern called Cheyne-Stokes respiration
  • People with a medical history that the trial investigators believe could interfere with the study's goals or affect the reliability of its results
  • People with medical, social, or personal circumstances that may make it difficult to follow the trial requirements — for example, high alcohol consumption (more than 80g per day for men or more than 60g per day for women), no stable place of residence, disorientation, or a history of not following medical instructions
  • People with any condition — heart-related or otherwise — that limits life expectancy to less than one year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 636920584

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital San Pedro de Logroño
Registry
ClinicalTrials.gov
Start date
28 October 2022
Est. completion
30 May 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Primary Outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov